Icade 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Nicolas Joly

최고 경영자

€728.0k

총 보상

CEO 급여 비율	42.7%
CEO 임기	1.6yrs
CEO 소유권	n/a
경영진 평균 재임 기간	1.8yrs
이사회 평균 재임 기간	5.3yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Nicolas Joly 의 보수는 Icade 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Jun 30 2024	n/a	n/a	-€953m
Mar 31 2024	n/a	n/a	-€1b
Dec 31 2023	€728k	€311k	-€1b

보상 대 시장: Nicolas 의 총 보상 ($USD 763.07K ) UK 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 2.14M ).

보상과 수익: Nicolas 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.

CEO

Nicolas Joly (41 yo)

1.6yrs

테뉴어

€727,972

보상

Mr. Nicolas Joly has been Chief Executive Officer of Icade since April 21, 2023. Mr. Joly served as Deputy Director-General at Mercialys and had been its Executive Vice-President since 2016. Mr. Joly joine...

리더십 팀

이름	위치	테뉴어	보상	소유권
Nicolas Joly	Chief Executive Officer	1.6yrs	€727.97k	데이터 없음
Christelle De Robillard	Chief Financial Officer	less than a year	데이터 없음	데이터 없음
Sophie Duval	Head of Consolidation & Accounting	no data	데이터 없음	데이터 없음
Anne-Violette Faugeras	Director of Financing & Investor Relations	1.8yrs	데이터 없음	데이터 없음
Jérôme Lucchini	General Secretary and Head of Governance	9.1yrs	데이터 없음	데이터 없음
Emmanuelle Baboulin	Head of the Commercial Property Investment Division	9.2yrs	데이터 없음	데이터 없음
Xavier de La Sudrie	Head of Financial Control	no data	데이터 없음	데이터 없음
Johannah Mrejen	Head of Asset Management	no data	데이터 없음	데이터 없음
Guillaume Tessler	Head of International Development - Icade Santé	no data	데이터 없음	데이터 없음
Henri Chapouthier	Head of Sustainable Development	no data	데이터 없음	데이터 없음
Cathy Baglin	Head of Employee Affairs	no data	데이터 없음	데이터 없음
Benjamin Ficquet	Head of Property Management & Responsible Operations	no data	데이터 없음	데이터 없음

1.8yrs

평균 재임 기간

49yo

평균 연령

경험이 풍부한 관리: 0K4O 의 관리팀은 경험 (평균 재직 기간 1.8 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Bernard Spitz	Director	4.1yrs	€33.25k	0% € 0
Gonzague de Pirey	Independent Director	5.6yrs	€28.00k	0.00011% € 1.9k
Frederic Thomas	Chairman of the Board	8.5yrs	€240.00k	0.000040% € 675.9
Olivier Mareuse	Director	13.5yrs	데이터 없음	0% € 0
Marianne Louradour	Director	5.1yrs	데이터 없음	0% € 0
Antoine Saintoyant	Director	4.1yrs	데이터 없음	0% € 0
Sophie Quatrehomme	Director	6.7yrs	데이터 없음	0% € 0
Florence Peronnau	Vice Chairman of the Board & Lead Independent Director	8.5yrs	€101.25k	0.000010% € 169.0
Alexandre Thorel	Director	2.7yrs	데이터 없음	데이터 없음
Olivier Lecomte	Independent Director	1.1yrs	데이터 없음	0.000010% € 169.0
Emmanuel Chabas	Director	5.6yrs	데이터 없음	0% € 0
Laurence Giraudon	Director	4.8yrs	데이터 없음	0% € 0

5.3yrs

평균 재임 기간

56.5yo

평균 연령

경험이 풍부한 이사회: 0K4O 의 이사회는 경험(평균 재직 기간 5.3 년)으로 간주됩니다.

Icade 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Icade, Annual General Meeting, Apr 19, 2024

Recent updates

Icade to Report Fiscal Year 2024 Results on Feb 18, 2025

Now 21% undervalued

First half 2024 earnings released: €2.38 loss per share (vs €6.80 loss in 1H 2023)

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

Dividend of €2.42 announced

Now 21% undervalued after recent price drop

Upcoming dividend of €2.42 per share

Final dividend increased to €2.42

Icade, Annual General Meeting, Apr 19, 2024

Icade to Report Q1, 2024 Results on Apr 22, 2024

Icade to Report First Half, 2024 Results on Jul 22, 2024

Icade to Report Fiscal Year 2023 Results on Feb 19, 2024

Icade(ENXTPA:ICAD) dropped from FTSE All-World Index (USD)

Now 20% undervalued after recent price drop

Primonial REIM and Société Générale Assurances completed the acquisition of 63% stake in Icade Santé SAS from Icade (ENXTPA:ICAD) and its Minority Shareholders.

Upcoming dividend of €2.17 per share at 12% yield

Vauban Infrastructure Partners and Icade (ENXTPA:ICAD) agreed to acquire A2A Coriance SAS.

Oteis France Sas agreed to acquire AMO and EXPERTISE SANTE activity from Icade (ENXTPA:ICAD).

An undisclosed buyer acquired Michigan Garden Project from Icade SA (ENXTPA:ICAD) for €108 million.

Icade SA (ENXTPA:ICAD) acquired Défense Parc complex in Nanterre Préfecture for €63 million.

Icade SA to Report Q1, 2023 Results on Apr 24, 2023

Icade SA to Report Fiscal Year 2022 Results on Feb 20, 2023

Investor sentiment deteriorated over the past week

Elysées Pierre signed a bilateral preliminary agreement to acquire 16,000-Sq.m AXE 13 Office Building in Nanterre from Icade (ENXTPA:ICAD).

Investor sentiment deteriorated over the past week

Upcoming dividend of €2.10 per share

Funds managed by Primonial REIM acquired Gambetta building in paris from Icade (ENXTPA:ICAD) for approximately €220 million.

Funds managed by Primonial REIM acquired Gambetta building in paris from Icade (ENXTPA:ICAD) for approximately €220 million.

Residences Le Logement Des Fonctionnaires SA signed a bilateral preliminary agreement to acquire Residual Residential Portfolio from Icade (ENXTPA:ICAD) for €49.9 million.

Icade (ENXTPA:ICAD) acquired 50.1% interest in M&A Group.

Full year 2021 earnings released: EPS: €5.33 (vs €1.03 in FY 2020)

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

An unknown buyer completed the acquisition of Office building in Boulogne-Billancourt from Icade SA (ENXTPA:ICAD).

First half 2021 earnings released: EPS €2.52 (vs €0.07 in 1H 2020)

Upcoming dividend of €2.00 per share

Revenue beats expectations

New 90-day low: €55.83

A pan-European fund dedicated to a German institutional investor managed by Aberdeen Standard Investments Limited acquired Two residential buildings in Rueil-Malmaison from Icade SA (ENXTPA:ICAD) for €14.6 million.

Icade SA (ENXTPA:ICAD) acquired Ad Vitam

Icade SA to Report Q1, 2021 Results on Apr 23, 2021

Icade SA (ENXTPA:ICAD) agreed to acquire Four Nursing Homes in France from Korian (ENXTPA:KORI) for €33.5 million.

New 90-day high: €67.93

New 90-day high: €64.00

Market bids up stock over the past week

New 90-day low: €48.18

New 90-day low - €53.65

OPPCI owned by South Korean Investors completed the acquisition of 49% stake in Eqho Tower from Icade (ENXTPA:ICAD).

Icade (ENXTPA:ICAD) completed the acquisition of Pointe Métro 1 in Gennevilliers from Fonciere NW 2 Sppicav managed by NORMANDIE REIM.

New 90-day low - €56.63

Icade SA (ENXTPA : ICAD) agreed to acquire Portfolio of 9 Healthcare Facilities in Germany & France from Orpea SA (ENXTPA : ORP) for €145 million.

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령